BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sakauchi F, Oura A, Ohnishi H, Mori M. Comparison of the clinical features of Japanese patients with primary biliary cirrhosis in 1999 and 2004: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol. 2007;17:210-214. [PMID: 18094520 DOI: 10.2188/jea.17.210] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Qin B, Liang Y, Yang Z, Zhong R. Effect of the polymorphisms of tumor necrosis factor-α gene on the susceptibility to primary biliary cirrhosis: a meta-analysis. Eur J Gastroenterol Hepatol 2012;24:1386-92. [PMID: 23011034 DOI: 10.1097/MEG.0b013e3283581f2e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Yang YL, Yang JP. Diagnosis of early primary biliary cirrhosis: an analysis of 15 cases. Shijie Huaren Xiaohua Zazhi 2008; 16(29): 3335-3337 [DOI: 10.11569/wcjd.v16.i29.3335] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Miyake Y, Ikeda F, Takaki A, Nouso K, Yamamoto K. +49A/G polymorphism of cytotoxic T-lymphocyte antigen 4 gene in type 1 autoimmune hepatitis and primary biliary cirrhosis: A meta-analysis. Hepatol Res. 2011;41:151-159. [PMID: 21269385 DOI: 10.1111/j.1872-034X.2010.00757.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
4 Loria P, Carulli L, Bertolotti M, Lonardo A. Endocrine and liver interaction: the role of endocrine pathways in NASH. Nat Rev Gastroenterol Hepatol. 2009;6:236-247. [PMID: 19347015 DOI: 10.1038/nrgastro.2009.33] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 6.4] [Reference Citation Analysis]
5 Someya S, Uchiyama A, Arai K, Kon K, Yamashina S, Watanabe S, Ikejima K. Gender-specific development of experimental autoimmune cholangitis induced by double-stranded RNA. Biochem Biophys Res Commun 2021;588:90-6. [PMID: 34953211 DOI: 10.1016/j.bbrc.2021.12.011] [Reference Citation Analysis]
6 Kumagi T, Alswat K, Hirschfield GM, Heathcote J. New insights into autoimmune liver diseases. Hepatol Res. 2008;38:745-761. [PMID: 18462376 DOI: 10.1111/j.1872-034x.2008.00366.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
7 Sugiyama K, Sada KE, Kurosawa M, Wada J, Makino H. Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan. Clin Exp Nephrol 2013;17:51-8. [PMID: 22760432 DOI: 10.1007/s10157-012-0651-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
8 Loria P, Carulli L, Bertolotti M, Lonardo A. Endocrine and liver interaction: the role of endocrine pathways in NASH. Nat Rev Gastroenterol Hepatol. 2009;6:236-247. [PMID: 19347015 DOI: 10.1038/nrgatro.2009.33] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Li M, Zheng H, Li T, Gao P, Zhang XL, Liu DW. Cytotoxic T-lymphocyte associated antigen-4 gene polymorphisms and primary biliary cirrhosis: a systematic review. J Gastroenterol Hepatol. 2012;27:1159-1166. [PMID: 22414241 DOI: 10.1111/j.1440-1746.2012.07118.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]